Incidence of early allograft rejection after descemet membrane endothelial keratoplasty

Cornea

Volumn 30, Issue 12, 2011, Pages 1341-1345

  Dapena, Isabel ^a   Ham, Lisanne ^a   Netuková, Magdaléna ^b   Van Der Wees, Jacqueline ^a   Melles, Gerrit R J ^a  

^a NETHERLANDS INSTITUTE FOR INNOVATIVE OCULAR SURGERY   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

allograft rejection; corneal transplantation; Descemet membrane endothelial keratoplasty; endothelial keratoplasty; endothelium; immune response

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUOROMETHOLONE;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CONGENITAL CORNEA DYSTROPHY; CORNEA; CORNEA ENDOTHELIUM; CORTICOSTEROID THERAPY; DESCEMET MEMBRANE; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; EYE; FEMALE; FINGER; FOLLOW UP; GRAFT REJECTION; HUMAN; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOPHAKIC BULLOUS KERATOPATHY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 81355160522     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31820d8540     Document Type: Article

References (32)

1. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402.
2. Dua HS, Azuara-Blanco A. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol. 1999;47:3-9.
3. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the Collaborative Corneal Transplantation Studies. Ophthalmology. 1994;101:1536-1547.
4. Claesson M, Armitage WJ, Fagerholm P, et al. Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register. Br J Ophthalmol. 2002;86:174-180.
5. Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye. 1995;9:219-227.
6. Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol. 2005; 140:1112-1122.
7. Küchle M, Cursiefen C, Nguyen NX, et al. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol. 2002;240: 580-584.
8. Allan BDS, Terry MA, Price FW Jr, et al. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007;26:1039-1042.
9. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, et al. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci. 2002;43:2264-2271.
10. Melles GRJ, Eggink FAGJ, Lander F, et al. A surgical technique for posterior lamellar keratoplasty. Cornea. 1998;17:618-626.
11. Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the Descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004;23:286-288.
12. Dapena I, Ham L, Melles GRJ. Endothelial keratoplasty. DSEK/DSAEK or DMEK: the thinner the better? Curr Opin Ophthalmol. 2009;20: 299-307.
13. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032-3042.
14. Koenig SB, Covert DJ, Dupps WJ Jr, et al. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea. 2007;26: 670-674.
15. Price MO, Jordan CS, Moore G, et al. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol. 2009;93: 391-395.
16. Lee WB, Jacobs DS, Musch DC, et al. Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2009;116:1818-1830.
17. Melles GRJ. Posterior lamellar keratoplasty. DLEK to DSEK to DMEK. Cornea. 2006;25:879-881.
18. Dapena I, Moutsouris K, Droutsas K, et al. Standardized-no touch-technique for Descemet membrane endothelial keratoplasty (DMEK). Arch Ophthalmol. 2011;129:88-94.
19. Ham L, Dapena I, van Luijk, et al. Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy. Review of the first 50 consecutive cases. Eye. 2009;23:1990-1998.
20. Lie JT, Birbal R, Ham L, et al. Donor tissue preparation for Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2008;34:1578-1583.
21. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
22. Kuffová L, Holán V, Lumsden L, et al. Cell subpopulations in failed human corneal grafts. Br J Ophthalmol. 1999;83:1364-1369.
23. Kuffová L, Lumsden L, Veselá V, et al. Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response. Transplantation. 2001;72:1292-1298.
24. Hegde S, Beauregard C, Mayhew E, et al. CD4 (+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation. 2005;79:23-31.
25. Kuffová L, Netuková M, Duncan L, et al. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice. J Immunol. 2008;180:1353-1361.
26. Han DC, Mehta JS, Por YM, et al. Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus. Am J Ophthalmol. 2009:148:744-751.
27. Kaplan HJ, Streilein JW. Analysis of immunologic privilege within the anterior chamber of the eye. Transplant Proc. 1977;9:1193-1195.
28. Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999;67:1503-1508.
29. Rocha G, Deschênes J, Rowsey JJ. The immunology of corneal graft rejection. Crit Rev Immunol. 1998;18:305-325.
30. Yamada J, Streilein JW. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Invest Ophthalmol Vis Sci. 1997;38:2833-2843.
31. McMenamin PG. Dendritic cells and macrophages in the uveal tract of the normal mouse eye. Br J Ophthalmol. 1999;83:598-604.
32. Steptoe RJ, McMenamin PG, Holt PG. Resident tissue macrophages within the normal rat iris lack immunosuppressive activity and are effective antigen-presenting cells. Ocul Immunol Inflamm. 2000;8:177-187.